HRTS

Investor Moves

Name	Value	Action	Change	Price	Current Price
Ken GriffinCitadel Advisors $-1.2M ExitQ2 2025 $1.2M -- --
Ken GriffinCitadel Advisors $-1.2M ExitQ2 2025 $1.2M -- --
Ken GriffinCitadel Advisors $-840.7K ExitQ3 2024 $841k -- --
Ken GriffinCitadel Advisors $-840.7K ExitQ3 2024 $841k -- --
Ken GriffinCitadel Advisors $-744.3K TrimQ2 2024 $744k -- --

News

zacks.comGLP-1 Drug Giants Race to Go Global With Their Obesity Pills: ETFs to Gainzacks.comMay 19

businesswire.comTema ETFs Surpasses $2 Billion in AUM in Under Three Yearsbusinesswire.comApr 16

Trade HRTS

About Tema Cardiovascular and Metabolic ETF

The Tema Heart & Health ETF (HRTS) is designed to strategically invest in companies poised to benefit from cutting-edge developments within the biotechnology and broader healthcare industries. Its investment mandate specifically targets firms focused on advancing treatments and therapies for cardiovascular health, metabolic disorders, and weight management.

IPO Date: Nov 21, 2023

Market Data

Open: $33.77
High: $33.92
Low: $33.71
Volume: 3.9K
Avg Volume: 5.2K
52W High: $36.65
52W Low: $27.24

Valuation

Market Cap: $52M
Dividend Yield: 47.3%

Financials

Financial statement snapshot is not available yet.

Events

DividendDec 10

$0.47291